Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 19.51 |
| Open | 19.54 |
| Bid | 20.33 x 200 |
| Ask | 20.44 x 100 |
| Day's range | 19.33 - 20.77 |
| 52-week range | 9.26 - 26.70 |
| Volume | |
| Avg. volume | 230,322 |
| Market cap | 561.122M |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
FRIENDSWOOD, Texas, April 11, 2024--Castle will release its financial results for the first quarter ended March 31, 2024, after the close of market on Thursday, May 2, 2024.
- Business Wire
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
FRIENDSWOOD, Texas, April 10, 2024--Castle recognizes the importance of Esophageal Cancer Awareness Month and is providing its support of key programs and initiatives throughout April.
- Business Wire
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
FRIENDSWOOD, Texas, April 10, 2024--For the second year in a row, Castle's chief financial officer, Frank Stokes, has been selected as a Top 25 CFO of Houston by TOP CFOs.
© 2024 Yahoo. All rights reserved.